Literature DB >> 9814593

HLA expression at the maternal-fetal interface.

H Hutter1, A Hammer, G Dohr, J S Hunt.   

Abstract

Pregnancy in the human presents an "immunological paradox," because of the unexpected willingness of mothers to accept genetically disparate tissues. The fact that the fetus can develop unharmed for nine months shows that protective mechanisms must exist to permit its survival. The conditions that permit the genetically dissimilar human fetus to evade rejection by its mother's immune system have been the subject of intense interest for several decades. As the placental cells, which are in contact with maternal blood or tissue, are devoid of HLA class II antigens, interest has focused on the expression of HLA class I molecules. Recent developments in the constitutive, transcriptional, and translational expression of HLA class I molecules on anatomically and morphologically different subpopulations of trophoblast cells will form the basis of this short review.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9814593      PMCID: PMC2276020          DOI: 10.1155/1998/65065

Source DB:  PubMed          Journal:  Dev Immunol        ISSN: 1026-7905


  3 in total

1.  Removing the vertebrate-specific TBP N terminus disrupts placental beta2m-dependent interactions with the maternal immune system.

Authors:  Nicole K Hobbs; Alla A Bondareva; Sheila Barnett; Mario R Capecchi; Edward E Schmidt
Journal:  Cell       Date:  2002-07-12       Impact factor: 41.582

Review 2.  Leptin action in normal and pathological pregnancies.

Authors:  Antonio Pérez-Pérez; Ayelén Toro; Teresa Vilariño-García; Julieta Maymó; Pilar Guadix; José L Dueñas; Manuel Fernández-Sánchez; Cecilia Varone; Víctor Sánchez-Margalet
Journal:  J Cell Mol Med       Date:  2017-11-21       Impact factor: 5.310

Review 3.  The role of placental indoleamine 2,3-dioxygenase in human pregnancy.

Authors:  Yoshiki Kudo
Journal:  Obstet Gynecol Sci       Date:  2013-07-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.